Clinical trial

An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities

NCT05532020

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-01-01

PhasePHASE2

Study timeline

Study start (estimated)2023-01-01Date precision: month

Registry last updated2022-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

SH2B1 Deficiency Obesityunresolved

Obesity Associated With PCSK1 Mutation (rs6232 Variant)unresolved

SIM1 Deficiency Obesityunresolved

Interventions

DCCR (diazoxide choline) extended-release tabletsDRUG

Sponsors & collaborators

Soleno Therapeutics, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05532020 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.